Ameliorate Biotech
PrivateLast Round
Grant
Feb 21, 2023
Total Funding Raised
$490,000
Company Overview
Ameliorate Biotech operates in Healthcare & Life Sciences and is based in Bangalore. Its latest recorded funding round was a Grant round in February 2023.
Ameliorate Biotech is a biotechnology company that develops recombinant therapeutic proteins and rapid diagnostic kits for infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ameliorate Biotech Comparables
Compare Ameliorate Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stellar Diagnostics India Private Limited | 80% | |
| Achira Labs Private Limited | 78% | |
| Bhat Bio-Tech India (P) Ltd | 75% |
For institutional investors. Book with your work email.
Ameliorate Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 21, 2023 | ||||
| Angel | Jun 9, 2020 | ||||
| Grant | Aug 31, 2017 |
For institutional investors. Book with your work email.
Ameliorate Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Biotechnology Industry Research Assistance Council | Grant |
| LetsVenture Online | Angel |
| PadUp Ventures | Angel |
| VINNERS | Angel |
| Dayananda Sagar Entrepreneurship Research & Business Incubator (DERBI) Foundation | Angel |
| Atal Incubation Centre - Jyothy Institute of Technology Foundation | Accelerator |
| Department of Scientific and Industrial Research | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 26, 2026
Grew 100% QoQ from 3 to 6 employees.
- Jan 2, 2026
Monthly visitors grew 365% MoM, reaching 493.
For institutional investors. Book with your work email.
Ameliorate Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ameliorate Biotech's valuation, stock price, and market status.
Is Ameliorate Biotech a public or private company?
Ameliorate Biotech is a private company.
What is the current stock price of Ameliorate Biotech?
Ameliorate Biotech is a private company, so its shares have no public market price. Caplight tracks Ameliorate Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ameliorate Biotech worth (valuation)?
Valuation information for Ameliorate Biotech is not publicly available.
Can I buy Ameliorate Biotech stock?
Ameliorate Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ameliorate Biotech's last funding round?
Ameliorate Biotech's most recent funding round was Grant on February 21, 2023.
Who are the main investors in Ameliorate Biotech?
Key investors in Ameliorate Biotech include Biotechnology Industry Research Assistance Council, LetsVenture Online, PadUp Ventures, VINNERS, Dayananda Sagar Entrepreneurship Research & Business Incubator (DERBI) Foundation.
Will Ameliorate Biotech IPO soon?
No public IPO plans have been announced for Ameliorate Biotech.
How can I track Ameliorate Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Ameliorate Biotech's shares on secondary markets.